Source: The Journal of Heart Disease. Conference titles: World Congress on Heart Disease. Unidade: FMRP
Subjects: MIOCARDIOPATIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Erica C et al. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. The Journal of Heart Disease. Beverly Hills: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 out. 2024. , 2012APA
Campos, E. C., Malvestio, L. M., Romano, M. D., Celes, M. N., Blefari, V., Prado, C. M., & Rossi, M. A. (2012). Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. The Journal of Heart Disease. Beverly Hills: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Campos EC, Malvestio LM, Romano MD, Celes MN, Blefari V, Prado CM, Rossi MA. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. The Journal of Heart Disease. 2012 ; 9( 1): 1.[citado 2024 out. 16 ]Vancouver
Campos EC, Malvestio LM, Romano MD, Celes MN, Blefari V, Prado CM, Rossi MA. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. The Journal of Heart Disease. 2012 ; 9( 1): 1.[citado 2024 out. 16 ]